Henry Schein

Henry Schein

Henry Schein started the business in 1932 at the depth of the Depression, operating from a pharmacist's belief that corporate responsibility and community support reinforce one another. The firm has translated that founding ethos into a sprawling corporate vehicle headquartered in Melville, New York, that now touches over one million customers worldwide. Schein's model rests on three interlocking capabilities: wholesale distribution of more than 300,000 medical and dental products, a proprietary technology stack under Henry Schein One that manages practice workflows, and financial services that help clinics equip themselves. The firm's operational chain — 4,800 supplier partners feeding distribution and manufacturing centers across multiple countries — delivers a historically tracked 99% fulfillment rate on 150,000 cartons shipped daily. Within oral health, the firm owns direct positions in specialty brands including BioHorizons, Camlog, and Zahn Dental Laboratories. A workforce of more than 25,000 Team Schein Members generated $13.2 billion in sales in 2025 (per firm disclosure, 2025). The company has ranked on the Fortune 500 every year since 2004. Its philanthropic arm, Henry Schein Cares, centralizes global corporate social responsibility, separating the charitable activities from the distribution and technology businesses while keeping them under the same corporate umbrella. Schein's structural advantage is its simultaneous control of physical supply and practice software within a single publicly traded entity, making it a vertically integrated operator rather than a pure logistics provider. That architecture gives the firm real-time visibility into clinic purchasing patterns while owning the digital interface — a combination that few healthcare distributors have assembled at comparable scale.